Arxis targets $11.2 billion valuation in US IPO: aerospace and defense listings heat up

Aerospace components maker Arxis is set to launch a US IPO, targeting a valuation of up to $11.2 billion and planning to raise roughly $1.06 billion, according to Reuters. The Bloomfield, Connecticut‑based company filed with regulators to offer 37.7 million shares at an expected price range of $25 to $28 per share, with Goldman Sachs, Morgan Stanley, and Jefferies leading the offering. Arxis will list on the Nasdaq under the ticker ARXS, signaling strong investor interest in aerospace & defense stocks and industrial tech IPOs amid market volatility.

The move highlights how aerospace and defense firms are drawing renewed capital markets attention, as geopolitical uncertainties boost demand for mission‑critical components. Backed by private equity firm Arcline Investment Management, Arxis’s IPO is one of the largest offerings from a defense supplier this year and comes as other aerospace and defense companies prepare public listings.

Growth through acquisitions and industrial focus

Arxis specializes in engineered electronic and mechanical components used in aerospace, defense, medical technology and niche industrial applications. The company has expanded rapidly since 2019, completing more than 30 acquisitions including the $1.8 billion purchase of Kaman Corporation in 2024 under Arcline’s ownership.

This acquisition‑led strategy reflects how private equity and industrial investors build scale in mission‑critical sectors. For Arxis, bolstering engineering capabilities and customer base through targeted deals has helped position the company as one of the larger suppliers in a fragmented supplier market, appealing to institutional investors focused on resilient revenue streams.

Defense and aerospace demand amid geopolitical shifts

The timing of the Arxis Nasdaq IPO reflects broader market trends, with defense and aerospace securities drawing attention amid ongoing geopolitical tensions, including conflicts in the Middle East and Ukraine that have elevated defense spending globally. Troy Hooper, co‑head of equity capital markets at Mergermarket, noted that in this environment, defense‑linked companies—especially those serving mission‑critical sectors—can attract investor interest even in challenging markets.

For investors, this means that companies with exposure to defense and aerospace markets are increasingly seen as defensive yet growth‑oriented assets, capable of delivering revenue resilience and long‑term structural demand.

IPO details: what investors should watch

Arxis’s proposed offering comprises 37.7 million Class A shares priced between $25 and $28, aiming to raise up to about $1.06 billion. If the offering priced at the midpoint, the net proceeds would be approximately $930 million, potentially rising above $1 billion with full exercise of underwriter options.

The company will use IPO proceeds to pay down debt and support working capital needs. Institutional investors including Capital International Investors, Capital Research Global Investors, Janus Henderson Investors and T. Rowe Price have indicated interest in purchasing up to $400 million of the offered shares, signaling strong demand from long‑term holders.

Underwriters and market positioning

Goldman Sachs, Morgan Stanley and Jefferies are serving as the lead joint bookrunning managers, with Citigroup and RBC Capital Markets also acting as joint bookrunners. Additional support is coming from Baird, Guggenheim Securities, Wells Fargo Securities, William Blair, Rothschild & Co and the Wolfe | Nomura Alliance.

Arxis’s listing on the Nasdaq Global Select Market positions the company alongside other industrial and aerospace technology leaders. It also serves as a benchmark for investor appetite in defense‑linked IPOs, which have recently included filings from other aerospace and tech companies.

What this means for IPO sentiment

The Arxis Nasdaq IPO contributes to a broader resurgence in listings among industrial and defense firms, following a period of market caution. Institutional interest at the scale indicated in the filing suggests that public markets are receptive to companies with defense exposure, recurring engineering revenue, and scalable industrial platforms.

Investors should watch how ARXS performs in early trading, as this will help gauge appetite for similar defense and aerospace listings later in 2026. Strong aftermarket performance could attract additional offerings from this sector, particularly for companies backed by private equity sponsors with acquisition‑driven growth strategies.

Bottom line for investors

Arxis’s IPO — with a potential valuation north of $11 billion — demonstrates that defense and aerospace manufacturers remain attractive candidates for public listings, even amid market volatility. The company’s acquisition‑led growth, diversified end markets and institutional demand position it as a compelling story for investors seeking exposure to mission‑critical technology sectors. As ARXS debuts on Nasdaq, it could help catalyze further IPO activity in aerospace and defense throughout 2026.

About UCapital.com

UCapital is a global financial intelligence and news platform. It combines timely market coverage and in-depth analysis with access to curated deal opportunities, connecting investors and financial professionals to private market activity.